St John of God Subiaco Hospital is considered a world leader in cancer research, providing patients access to some the most innovative treatments available.
Our research program spans a broad range of clinical areas, including oncology, neurosurgery, orthopaedics, intensive care and respiratory medicine.
Explore our latest hospital research report to discover the remarkable achievements across our research portfolio.
Research units
Explore each research unit to find out more about the projects, publications, researchers and clinical trials underway.
-
Anaesthesia and pain research
A leading research unit in WA for muti-centre clinical trials and guidance in anaesthesia, pain and perioperative medicine. -
Breast cancer research
Focuses on improving the health care and lifestyles of those affected by breast cancer. -
Colorectal Cancer Research
Aims to improve surgical outcomes and survival rates for patients with colorectal cancer. -
Gynaecological Cancer Research
We are a leader in local, national and international gynaecological cancer research with a focus on improving the quality of life for ovarian cancer survivors. -
Intensive care research
Providing supportive care which aims to aid general recovery by supporting organ systems of the body. -
-
Thoracic Research
Key research areas include respiratory medicine, lung cancer and thoracic oncology. We are the largest respiratory and respiratory oncology research group in WA’s private sector.
Key research areas include respiratory medicine, lung cancer and thoracic oncology. We are the largest respiratory and respiratory oncology research group in WA’s private sector.
Research at St John of God Health Care
Subiaco Clinical Trials Unit
The Clinical trial unit at St John of God Subiaco Hospital is committed to ongoing research of cancer treatment and outcomes, ensuring our patients receive the most advanced contemporary treatment as well as contributing to the wider body of knowledge in relation to cancer.
The Subiaco Clinical Trial Unit has a strong record of providing vital treatment opportunities for patients consistent with the hospital’s clinical service provision. Areas of focus include pancreatic, ovarian, endometrial, breast, lung, upper gastrointestinal, prostate, renal and colorectal cancers. The unit engages in commercially-sponsored, investigator-initiated and cooperative research group trials, from early-phase first-in-human, to late phase trials, with a specific focus on areas of unmet need.